等待开盘 08-06 09:30:00 美东时间
-0.040
-0.17%
Wells Fargo analyst Finian O'Shea maintains Sixth Street Specialty (NYSE:TSLX) with a Overweight and raises the price target from $21 to $24.
08-01 22:07
Sixth Street Specialty Lending (NYSE:TSLX) declares $0.06/share quarterly dividend. Payable June 20; for shareholders of record May 30; ex-div May 30. See TSLX Dividend Scorecard, Yield Chart, & Divid...
05-26 19:13
Here are the most recent stock upgrades and downgrades by Seeking Alpha analysts. Upgrades: Broadcom (NASDAQ:AVGO) upgraded to buy from sell by Prop Notes. "The recent selloff in AVGO stock represent...
04-07 23:12
Managing partner and investment chief at private equity firm Symphony Technology Group (STG), William Chisholm, along with a syndicate of investors, struck a $6.1B deal to buy the Boston Celtics baske...
03-21 01:26
Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and Arista Networks.
03-14 20:22
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1102154574572916737.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Prothena Corp(PRTA)"超配"评级,目标价从94美元升至110美元</p> <p>• Stifel:维持GH Research(GHRS)"买入"评级,目标价从18美元升至3
02-28 09:50
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1101791398596456448.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Prothena Corp(PRTA)"超配"评级,目标价从94美元升至110美元</p> <p>• HC Wainwright & Co.:维持Karyopharm Therape
02-27 11:06
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1098890886600560640.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Stoke Therapeutics(STOK)"买入"评级,目标价从35美元升至47美元</p> <p>• HC Wainwright & Co.:维持万达生物
02-19 10:24
Analysts' ratings for Sixth Street Specialty (NYSE:TSLX) over the last quarter ...
02-19 02:01
Oppenheimer:上调Ovid Therapeutics(OVID)评级至"跑赢大市",目标价4美元
01-30 16:06